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Feline infectious peritonitis (FIP) is a worldwide disease 
of domestic and wild felids caused by the virulent bio-
type of feline coronavirus (FCoV), sometimes referred to 
FIP virus (FIPV).1–3 It has been reported that mainly 
young cats aged 6 months to 2 years and male cats are 
affected.4–10 Furthermore, some breeds are thought to be 
predisposed to developing FIP.6–12 Clinical signs are 
mainly non-specific, such as recurrent fever, anorexia, 
chronic weight loss, and central nervous system (CNS) 
signs or ocular changes.4,13 Effusion can occur in visceral 
cavities due to serositis.14 Ante-mortem diagnosis of FIP 
is challenging as there are no pathognomonic clinical 
signs or laboratory changes. The examination of effusion 
by the use of immunofluorescence staining of FCoV anti-
gen in macrophages is highly specific but is complicated 
by the often low numbers of macrophages in the effusion 
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Abstract
Objectives The objectives of this study were to review signalment, clinical signs and laboratory features in a large 
number of naturally occurring cases of feline infectious peritonitis (FIP), and to evaluate potential changes in 
diagnostic criteria for FIP and compare findings in cats with and without effusion.
Methods The medical records of 231 cats with confirmed FIP that presented to the Clinic of Small Animal Medicine 
of the Ludwig-Maximilian University of Munich, Germany, were reviewed for signalment, history, and clinical and 
laboratory parameters. Age, sex and breed distribution of the cats were compared with the clinic population.
Results Male sex and young age were significantly correlated with FIP. Neutering status was not associated with 
FIP. No breed predisposition was observed and the majority of cats presented were domestic shorthair and mixed 
breed. Microcytosis of peripheral erythrocytes was found in 35.1% of cats, of which 42.4% did not have concurrent 
anaemia. Band neutrophilia was documented in 44.3% (81/183), of which 35.8% did not have mature neutrophilia. 
Lymphopenia, observed significantly more often with effusion, was documented in only 26.8% of cats without 
effusion. Hyperbilirubinaemia also occurred significantly more often in cats with vs without effusion. While serum 
total protein was increased in only 17.5% of cats, hyperglobulinaemia was documented in 89.1%. Nearly 85.0% of 
cats had an albumin-to-globulin (A:G) ratio <0.8, while 67.8% had an A:G ratio <0.6.
Conclusions and relevance Microcytosis was common and can increase suspicion of FIP in the presence of other 
typical clinical and laboratory abnormalities. The low prevalence of lymphopenia in cats without effusion suggests 
that this is not a useful parameter in non-effusive FIP. The frequent occurrence of a left shift in the absence of a 
mature neutrophilia complicates the differentiation of effusive FIP and septic peritonitis. Globulins and A:G ratio 
were of higher diagnostic value than hyperproteinaemia.
Accepted: 6 April 2015
1 Clinic of Small Animal Medicine, Ludwig-Maximilian University, 
Munich, Germany
2 Clinic for Ruminants with Ambulatory and Herd Health Services, 
Ludwig-Maximilian University, Munich, Germany
Corresponding author:
Friederike Riemer, Clinic of Small Animal Medicine, Ludwig-
Maximilian University, Veterinärstrasse 13, 80539 Munich, 
Germany 
Email: friederike.riemer@gmail.com
586209 JFM0010.1177/1098612X15586209Journal of Feline Medicine and SurgeryRiemer et al
research-article2015
Original Article
Riemer et al 349
and, also, is of no use in those cats without effusion.15,16 
While immunohistochemical staining can also be applied 
to organ biopsy specimens, FIP is generally considered 
substantially more difficult to diagnose definitively in 
vivo in cats without vs with effusion as clinical signs and 
laboratory features are more vague.16
Several studies have looked at clinical and laboratory 
abnormalities in cats with FIP. However, most of these 
studies contained either a smaller number of cats or only 
evaluated signalment.4–10,17–20 In addition, the last data 
from Europe were published almost 20 years ago.4,19 
Therefore, the aims of the study were to re-examine sig-
nalment, and clinical and laboratory features in a large 
group of cats with confirmed FIP and to compare find-
ings in those cats with and without effusion evaluating 
differences in clinical and laboratory parameters.
Materials and methods
Selection of cases
This study retrospectively evaluated the medical records 
in the computerised database of the Clinic of Small 
Animal Medicine (CSAM) of the Ludwig-Maximilian 
University, Munich, Germany, between 2000 and 2010. 
Out of 16,715 cats registered in the CSAM between 1 
January 2000 and 15 September 2010, 231 cats with a 
definitive diagnosis of FIP were identified. A diagnosis 
of FIP was considered definitive if (1) immunofluores-
cence staining of effusion revealed FCoV antigen in mac-
rophages (n = 38),15 or (2) tissue samples collected 
during necropsy (n = 185) or surgery (n = 8) showed 
histological lesions characteristic of FIP.21–25 Signalment, 
history, results of the clinical examination and laboratory 
results were obtained from the medical records. Fever 
was classified as temperature >39.0°C. In some statisti-
cal tests a cutoff of ⩾39.5°C was selected in an attempt to 
exclude cats with stress-induced hyperthermia.
Statistical analysis
Statistical analysis was performed using commercial soft-
ware (SPSS Version 18 [IBM]; StatCalc 5.4.1). Descriptive 
statistics were performed for all evaluated variables. 
Categorical data were analysed using a χ2 test. In 2 × 2 
contingency tables with any expected cell values <5, 
Fisher’s exact two-tailed results were used. Additionally, 
the Mann–Whitney test was used to compare non- 
categorical data between groups. Age, sex, reproductive 
status and breed distribution of cats with FIP were com-
pared with the feline clinic population presented to the 
CSAM from 1 January 2000 to 15 September 2010. History, 
clinical signs and laboratory parameters were compared 
within the group of cats with FIP. A Bonferroni correction 
was performed to rule out multiple test interference, and 
P ⩽0.01 for each individual parameter was considered 
significant. A multivariate analysis was used to compare 
age, sex and neutering status.
Results
Signalment
Cats with FIP were significantly younger than the clinic 
population (P <0.001) and FIP occurred significantly 
more often in cats younger than 2 years of age (P 
<0.001). In contrast, cats with FIP older than 7 years 
were significantly under-represented (P <0.001) when 
compared with the clinic population (Table 1). Male sex 
was significantly associated with FIP (P <0.001) (Table 
1). The age of cats with FIP ranged from 2 weeks to 19 
years (median 1.5 years, mean 3.7 years, interquartile 
range [IQR] 5.0) and did not differ significantly between 
males (median 1.8 years, mean 4.2 years, IQR 6.0) and 
females (median 1.0 years, mean 2.7 years, IQR 2.8). 
When controlling for age, the reproductive status of nei-
ther sex was associated with disease. Purebred cats were 
not over-represented when compared with the clinic 
population.
History
Where the housing density was recorded in the clinical 
record, almost two-thirds of cats with FIP (107/158; 
65.9%) lived in a single- or two-cat household at the time 
of diagnosis; 59.9% (100/167) were indoor cats, while 
40.1% (67/167) were permitted to roam outdoors. 
Specific stressful events preceding diagnosis were docu-
mented for 131/231 cats (Table 2).
Clinical signs
The clinical signs that were documented are listed in 
Table 3. On history, fever (⩾39.0°C) was documented in 
55.8% (120/215) of cats with FIP. Of the 111 cats with FIP 
for which the temperature was documented on physical 
examination, the majority (91/111; 81.0%) had a temper-
ature above 39.5°C, with nearly half (n = 43) of these cats 
being severely pyrexic with a temperature >40°C. Cats 
with CNS signs were less likely to have fever ⩾39.5°C 
(odds ratio 0.0.31, 95% confidence interval 0.12–0.77; P = 
0.005) than those without CNS signs. Effusion was 
detected in 78.1% (175/224) of cats with FIP. Of these, the 
majority (78.3%; 137/175) had ascites. Cats with effusion 
were significantly more likely to have fever ⩾39.0°C and 
less likely to have CNS signs (Table 3).
Haematology
Haematological changes were observed in nearly every 
cat (99.5%; 199/200) (Table 4). Severe anaemia, classified 
as a haematocrit ⩽10%, was uncommon and docu-
mented in only five cats (4.7%). Two of these five cats 
had reticulocytosis and hyperbilirubinaemia consistent 
with haemolytic anaemia. Microcytosis was detected in 
more than one-third of cats with FIP (35.1%; 66/188). 
Over 40% of these cats were not anaemic (28/66; 42.4%). 
Microcytosis was not associated with anaemia (P = 
0.445) or age (P = 0.225). Lymphopenia was recorded in 
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49.5% of cats with FIP (89/184) and was observed sig-
nificantly more often in cats with effusion (Table 5). Band 
neutrophilia (>500/µl) was documented in 44.3% 
(81/184) of cats with FIP. More than one-third of cats 
with a left shift (35.8%; 29/81) did not have a simultane-
ous elevation in segmented neutrophils. There was no 
correlation between fever (>39.9°C) and either mature 
(P = 0.588) or band neutrophilia (P = 0.895).
Serum biochemistry
Changes on the serum biochemistry profile were observed 
in 99.5% (186/187) of cats with FIP (Table 5). Elevated 
serum bilirubin was significantly more common in 
cats with effusion (Table 6), and there was no correlation 
with elevated liver enzymes (P = 0.233). Over one-third 
of cats with hyperbilirubinaemia had an anaemia 
without elevated liver enzymes (38/109; 34.9%). 
Hyperproteinaemia was documented in only 17.5% 
(32/183) of cats with FIP. An increase in serum total pro-
tein was significantly less likely in cats with effusion than 
in cats without effusion. Hyperglobulinaemia, docu-
mented in 89.1% (163/183) of cats, was not significantly 
associated with effusion. Nearly 85.0% (155/183) of cats 
with FIP had an albumin:globulin (A:G) ratio <0.8, while 
67.8% (124/183) of cats had an A:G ratio <0.6. A:G ratios 
Table 1 Signalment of cats with feline infectious peritonitis (FIP) compared with the clinic population
Cats with FIP (n = 231) Clinic population (n = 16,275) P value* OR (95% CI)
Sex  
Male 151 (65.4) 8849 (54.4) <0.001 1.58 (1.20–2.10)
 Intact 57 (24.7) 2065 (12.7)  
 Neutered 94 (40.7) 6778 (41.7)  
Female 80 (34.6) 7426 (45.6)  
 Intact 42 (18.2) 2275 (14.0)  
 Spayed 38 (16.4) 5145 (31.6)  
Age groups (years) n = 222 n = 15,724  
 <1 87 (39.2) 1986 (12.6) <0.001 4.46 (3.36–5.91)
 ⩾1–2 33 (14.9) 927 (5.9) <0.001 2.79 (1.88–4.11)
 >2–4 32 (14.4) 1895 (12.1)  
 >4–7 25 (11.3) 2189 (13.9)  
 >7–11 16 (7.2) 3277 (20.8) ∙ <0.001 0.19 (0.14–0.27)
  >11 29 (13.1) 5450 (34.7)
Breed n = 229 n = 15,685  
 DSH/mixed 185 (80.1) 12,356 (78.8)  
 Persian 9 (3.9) 926 (5.9)  
 Maine Coon 7 (3.1) 720 (4.6)  
 Birman 6 (2.6) 106 (0.7)  
 British shorthair 5 (2.2) 296 (1.9)  
 Siamese 4 (1.7) 323 (2.1)  
 Chartreux 4 (1.7) 106 (0.7)  
 NFC 4 (1.7) 224 (1.4)  
 Oriental shorthair 2 (0.9) 45 (0.3)  
 Devon Rex 2 (0.9) 12 (0.1)  
 Sphynx 1 (0.4) 1 (0.0)  
Data are given as n (%)
*Significance P ⩽0.01 (χ2 test). OR = odds ratio; CI = confidence interval; DSH = domestic shorthair; NFC = Norwegian Forest Cat
Table 2 Frequency of documented stress situations and 
keeping conditions of cats with feline infectious peritonitis 
(FIP)
Animals
Stress (n = 131)*  
 Adoption 38 (29.0)
 Animal shelter 31 (23.7)
 Surgery 29 (22.1)
 Upper respiratory tract disease 12 (9.2)
 Vaccination 9 (6.9)
 Household with other cats with FIP 8 (6.1)
 Boarding 6 (4.6)
 Breeding 6 (4.6)
 New cat in household 4 (3.0)
 Ran away 1 (0.8)
Keeping condition (n = 167)  
 Indoor 100 (59.9)
 Outdoor   67 (40.1)
Housing density (n = 158)  
 Single cat 29 (18.3)
 1 cat 75 (47.5)
 2 cats 20 (12.7)
 3 cats 7 (4.4)
 >3 cats 27 (17.1)
Data are given as n (%)
*Some cats had multiple stressors
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did not differ significantly between cats with and without 
effusion. Low albumin levels were significantly more com-
mon in cats with effusion, while azotaemia was detected 
significantly more often in cats without effusion.
Discussion
This retrospective study examined signalment, history, 
and the clinical and laboratory features of a large group 
of cats with confirmed FIP. To our knowledge, compara-
ble studies of a large number of cats with FIP, evaluating 
signalment, history, clinical signs and laboratory data, 
have not been performed in the past 20 years in Europe.4,19
As reported previously,4,6,7,9,10 this study detected FIP 
significantly more often in male cats. The role of sex-spe-
cific differences in the immune system is still not clear, 
especially in regard to cell-mediated immunity.7 Sex ster-
oid hormones exert influence on cell-mediated immu-
nity by affecting T-cell function.26 Androgens can 
dampen the immune response,27 which could potentially 
increase virus multiplication, thereby raising the risk of 
mutations of the viral genome thought to cause FIP. 
Consequently, hormonal influences on cell-mediated 
immunity might play a key role in the development of 
FIP, explaining the predisposition of male cats observed 
in multiple studies.4,6,7,9,10 Alternatively, sex-linked genes 
could potentially be responsible for predisposing male 
cats to FIP. In humans, for example, mutations on the Y 
chromosome are known to lead to several diseases, such 
as hearing impairment or a higher risk of developing 
coronary artery disease.28,29 Genes directly influencing 
the immune system might also be sex-linked, as demon-
strated by an experimental study, which established a 
mouse strain with Y chromosome–linked hereditary B- 
and natural killer-cell deficiencies.30
Several studies have found that cats with FIP are sig-
nificantly more likely to be intact,4,6,8,9 especially male 
cats.4,6 Upon adjusting for age, Rohrbach et al observed 
an over-representation of intact males, while spayed 
females were under-represented.6 They postulated that 
this was likely due to differences in behavioural patterns 
of spayed females vs sexually intact male cats.6 A higher 
prevalence of intact male cats with FIP is also consistent 
with the above hypothesis that sex steroid hormones, 
specifically androgens, negatively influence immunity. 
Castrated males produce less androgen and therefore 
should be less prone to developing FIP. The present 
study, however, found no correlation between FIP and 
neutering status in either sex after controlling for age. 
Perhaps the effect of hormonal status on the develop-
ment of FIP is counterbalanced by the stress of surgery 
from neutering. Stress is known to suppress the immune 
system, thus increasing the risk of FIP via a higher rate of 
viral replication and risc of mutations.
Interestingly, the majority (65.8%) of cats lived in a 
single-cat household (18.3%) or together with just one 
other cat (47.5%) at the time of diagnosis. This is 
Table 3 Historical and physical findings in cats with feline infectious peritonitis and the correlation with having effusion
Clinical signs n (%)  
Distribution of effusion 175/224 (78.1)  
 Ascites 137/175 (78.3)  
 Thoracic effusion 23/175 (13.1)  
 Ascites and thoracic effusion 14/175 (8.0)  
 Ascites and pericardial effusion 1/175 (0.6)  
 Association with effusion  
 With effusion, n (%) P value* OR (95% CI)
Lethargy, depression 194/222 (87.4) 149/190 (78.4) 0.320  
Inappetence 144/217 (66.4) 113/143 (79.0) 0.490  
Fever (°C) 111/190 (58.4) 99/117 (84.6) 0.004 2.58 (1.26–5.28)
 Mild (39.0–39.4) 20/111 (18.0)  
 Moderate (⩾39.5–40.0) 48/111 (42.3) 77/88 (87.5) 0.019  
 Severe (>40.0) 43/111 (38.7)  
Weight loss 82/219 (37.4) 64/80 (80.0) 0.733  
Vomitus, diarrhoea 36/220 (16.4) 28/36 (77.8) 1.000  
Dyspnoea 17/220 (7.7) 14/16 (87.5) 0.534  
Neurological signs 39/221 (17.6) 18/39 (46.2) <0.001 0.16 (0.07–0.36)
 Ataxia 14/39 (35.9)  
 Seizures 10/39 (25.6)  
 Vestibular syndrome 9/39 (23.1)  
 Paresis, paralysis 5/39 (12.8)  
 Somnolence 1/39 (2.6)  
*Considered significant if P ⩽0.01
OR = odds ratio; CI = confidence interval
∙
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surprising as housing density is regarded as a major risk 
factor for FIP.16,31–36 A likely explanation is previous 
exposure to FCoV before the young cats changed from a 
multi-cat environment into the new household with pro-
longed carriage of FCoV.
On haematology, microcytosis was detected in over 
one-third of cats with FIP. Interestingly, 40.0% (27/66) of 
these cats with microcytosis were not anaemic. 
Microcytosis is not well described in cats. A study exam-
ining blood samples in young cats aged 2–10 weeks 
detected microcytosis in the 2–4-week-old group. These 
kittens had lower serum iron and transferrin saturation 
values.37 Although young cats with FIP were significantly 
over-represented, in the present study, microcytosis did 
not correlate with age. In humans, microcytosis is a result 
of haemoglobinopathies due to iron deficiency, lead tox-
icity, chronic disease, thalassaemia trait or sideroblastic 
anaemia.38,39 While the microcytosis seen in cats with FIP 
could potentially be due to iron sequestration caused by 
chronic disease, anaemia of chronic disease in cats is 
more commonly associated with normocytic anaemia.40 
Reduced intestinal iron absorption due to hepcidin is a 
more likely explanation for FIP-associated microcytosis. 
This protein that inhibits iron uptake in the gut is 
stimulated by interleukin-1 and interleukin-6,41 which 
have been shown to be elevated in cats with FIP.42–44 As 
microcytosis with and without anaemia was commonly 
observed in cats with FIP in the present study, the pres-
ence of this laboratory abnormality in a cat with other 
clinical and laboratory parameters suggestive of FIP can 
increase the suspicion of this disease.
Lymphopenia, thought to be caused by virus-induced 
apoptosis of T cells and observed in 49.5% of 126 cats in 
the present study, is considered the most common hae-
matological abnormality in both effusive and non-effu-
sive FIP.16,17,45–47 Whereas Sparkes et  al observed no 
significant difference in the lymphocyte count of cats 
with effusion vs those without effusion,19 the present 
study documented lymphopenia significantly more 
often in cats with effusion (78/139; 56.1%). Only 26.8% 
(11/41) of cats without effusion had a reduced lympho-
cyte count. A possible explanation for the significantly 
higher prevalence of lymphopenia in cats with effusion 
could be the perivascular migration of lymphocytes sec-
ondary to vasculitis in cats with effusion.23,48 This find-
ing suggests that lymphopenia, considered a frequently 
observed, if non-specific laboratory change in cats with 
FIP,16,47 might not be as common an abnormality in the 


















Packed cell volume (l/l) 0.30–0.44 200 0.07–0.52 0.30 0.29 86 (43.0) 106 (53.0) 8 (4.0)
 Mild anaemia >0.20–0.30 106 85 (80.2)  
 Moderate anaemia 0.11–0.20 106 16 (15.1)  
 Severe anaemia ⩽0.10 106 5 (4.7)  
Red blood cells (× 1012/l) 5.0–10.0 199 1.68–12.80 7.28 7.23 155 (77.9) 24 (12.1) 20 (10.1)
Haemoglobin (mmol/l) 5.6–9.3 199 1.44–28.30 6.26 6.09 124 (62.3) 66 (33.2) 9 (4.5)
Mean cell volume (fl) 40.0–50.0 187 29.20–52.80 41.45 41.70 118 (63.1) 66 (35.3) 3 (1.6)
MCHC (mmol/l) 19.0–22.0 187 0.30–24.80 20.35 20.30 162 (86.6) 10 (5.3) 15 (8.0)
Thrombocytes (× 109/l) 180.0–550.0 115 50.00–745.00 258.82 240.00 77 (67.0) 32 (27.8) 6 (5.2)
White blood cell count  
(× 109/l)
6.0–11.0 200 2.02–77.00 17.26 19.10 48 (24.0) 13 (6.5) 139 (69.5)
Monocytes (× 109/l) 0.04–0.50 184 0–2.00 0.35 0.24 95 (51.6) 45 (24.5) 44 (23.9)
Lymphocytes (× 109/l) 1.0–4.0 184 0–7.76 1.46 1.02 81 (44.0) 91 (49.5) 12 (6.5)
Segmented neutrophils  
(× 109/l)
3.0–11.0 184 0.98–72.38 14.38 12.08 71 (38.6) 8 (4.3) 105 (57.1)
  Neutrophilia with left shift 105 52 (49.5)
   Neutrophilia without left 
shift
105 53 (50.5)
Band neutrophils (× 109/l) 0–0.6 184 0–8.76 1.01 0.46 103 (56.0) – 81 (44.0)
 Mild left shift 0.6–1.0   81 24 (29.7)
 Moderate left shift >1.0–2.0   81 30 (37.0)
 Severe left shift >2.0   81 27 (33.3)
Basophils (× 109/l) 0–0.04 184 0–0.02 0.0001 0 184 (100.0) – 0 (0)
Eosinophils (× 109/l) 0.04–0.06 184 0–5.00 0.09 0 27 (14.7) 150 (81.5) 7 (3.8)
MCHC = mean cell haemoglobin concentration
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difficult-to-diagnose group of FIP cats without effusion 
as previously thought.
A mature neutrophilia, often accompanied by a left 
shift, is commonly observed in cats with FIP.4,17,18 This 
neutrophilia is most likely due to non-specific reactive 
changes of the bone marrow, namely neutrophilic granu-
locyte hyperplasia with a left shift of the granulocytic 
series in cats with FIP.49 In the present study, band neu-
trophilia – usually in form of a moderate-to-severe left 
shift (>1000/µl; range 1000–8760/µl) – was observed in 
44.3% (81/184) of cats with FIP. Interestingly, 29/81 cats 
(35.8%) had a left shift without mature neutrophilia, a 
finding more commonly expected in cases of septic peri-
tonitis,50,51 an important differential diagnosis to FIP in 















ALT (U/l) 0–114.00 165 0–1428.00 76.47 36.00 141 (85.5) – 24 (14.5)
AST (U/l) 0–63.00   38 8.00–730.00 64.25 25.00 25 (65.8) – 13 (34.2)
ALP (U/l) 0–94.00 162 2.00–210.00 28.01 17.00 154 (95.1) – 8 (4.9)










Urea (mmol/l) 5.00–11.30 186 3.05–62.50 8.92 6.73 128 (68.8) 29 (15.6) 29 (15.6)
Creatinine 
(µmol/l)
0–169.00 185 17.00–627.00 89.15 75.00 177 (95.7) – 8 (4.3)
Total protein 
(g/l)
57.00–80.00 183 14.10–136.80 76.69 74.00 133 (72.7) 18 (9.8) 32 (17.5)
Albumin (g/l) 26.00–56.00 183 8.20–48.10 24.87 24.00 65 (35.5) 118 (64.5) 0 (0)
Globulins (g/l) >50.00 183 5.90–117.20 51.78 49.80 20 (11.0) – 163 (89.0)
Albumin/globulin 
ratio
<0.80 183 0.15–2.54 0.55 0.50 28 (15.3) 155 (84.7) –
 <0.60 183 0.15–2.54 0.55 0.50 59 (32.2) 124 (67.8) –
α1-globulin (g/l) 2.00–13.00   47 0.10–8.40 1.81 1.40 19 (40.4) 28 (59.6) 0 (0)
α2-globulin (g/l) 4.00–11.00   47 0.70–61.40 9.36 8.50 12 (25.5) 18 (38.3) 17 (36.2)
β-globulin (g/l) 3.00–15.00   47 4.80–29.30 14.24 12.30 28 (59.6) 0 (0) 19 (40.4)
γ-globulin (g/l) 6.00–26.00   47 2.50–101.10 27.86 24.50 21 (44.7) 4 (8.5) 22 (46.8)
ALT = alanine aminotransferase; AST = aspartate aminotransferase; ALP = alkaline phosphatase
Table 6 Significant correlations in cats with feline infectious peritonitis between clinical signs, blood parameters  
and presence of effusion
Cats with effusion Cats without effusion P value† OR 95% CI
Clinical signs  
 Fever (⩾39.0°C) 99/163 (60.7) 18/48 (37.5) 0.004 2.58 1.26–5.28
 Neurological signs 18/168 (10.7) 21/49 (42.9) <0.001 0.16 0.07–0.36
Blood parameters  
 Lymphocytes ↓ 78/139 (56.1) 11/41 (26.8) 0.001 3.49 1.53–8.09
 Bilirubin ↑ 91/134 (67.9) 15/35 (42.9) 0.006 2.82 1.24–6.48
 Urea ↑ 17/141 (12.1) 12/39 (30.8) 0.005 0.31 0.12–0.78
 Creatinine ↑ 2/141 (1.4) 6/39 (15.4) 0.001 0.08* 0.01–0.46
 Total protein ↑ 19/141 (13.5) 12/36 (33.3) 0.005 3.24 1.28–8.16
 Albumin ↓ 97/141 (68.8) 20/36 (55.6) 0.007 2.76 1.23–6.22
Data are given as n (%)
*Two-tailed Fisher’s exact test used because of small numbers
†Considered significant if P ⩽0.01 
OR = odds ratio; CI = confidence interval
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cats presenting with fever and effusion. In the absence of 
toxicity, this could potentially complicate the differentia-
tion of effusive FIP from a septic abdomen, especially in 
cats pretreated with antibiotics.
Similar to former studies, hyperbilirubinaemia, a 
common serum abnormality in cats with FIP, was mostly 
moderate-to-severe (>8.0 µmol/l; range 8.0–209.1 
µmol/l).4,10,19,20 As expected, high bilirubin values were 
not correlated with elevated liver enzymes, as hyperbili-
rubinaemia in cats with FIP is not a reflection of paren-
chymal liver disease but rather is due to excessive 
erythrocyte fragility leading to an increased destruction 
of red blood cells.52 The ensuing breakdown products of 
haemoglobin, bilirubin and biliverdin accumulate as a 
result of the cat’s intrinsically poor glucuronidation 
capacity.53 Previous studies have reported elevated bili-
rubin levels in nearly 90% of FIP cats with effusion.19,20 In 
the present study, hyperbilirubinaemia was significantly 
more common in cats with effusion (91/134; 67.9%) than 
in cats without effusion (15/35; 42.8%), possibly due to 
the more severe vasculitis underlying effusive FIP. 
Inflammation is known to compromise biliary metabo-
lism and excretion in the liver because endotoxins and 
cytokines cause a decreased gene expression of hepato-
cellular transporters needed for bile salt transport.54 
Thus, in patients with inflammation due to sepsis, for 
example, the basolateral and canalicular transport of bile 
acids is decreased causing insufficient transport of bili-
rubin out of the blood.55 Finally, although hyperbilirubi-
naemia is considered one of the cardinal clinical signs of 
FIP,4,10,16,19,20 a lack of this abnormality should not lead to 
a decrease in suspicion of this disease in cats without 
effusion, as only less than half (42.8%) of cats with non-
effusive FIP in this study had elevated bilirubin levels.
An increase in total serum globulins, especially 
γ-globulins, is another commonly observed biochemical 
abnormality in cats with FIP thought to result mainly 
from non-specific immune responses.16,56–58 Past studies 
documented increased serum globulin levels in 39–66% 
of FIP cats.4,10,19 In the present study, hyperglobulinae-
mia was detected in 89.1% of cats (163/183) irrespective 
of effusion, indicating that this is a fairly sensitive albeit 
non-specific diagnostic test not only in cats with, but also 
without, effusion.
In previous studies, serum γ-globulin concentrations 
were found to have a high positive predictive value 
(PPV) for FIP.15,59 Determination of serum globulin frac-
tions via protein electrophoresis was performed in only 
47 cats in the present study, 48.9% (23/47) of which had 
a γ-globulin concentration ⩾2.5 g/dl. This γ-globulin 
concentration was found to be the optimal cut-off value 
by Hartmann et al,15 with a specificity of 99%, a sensitiv-
ity of 35% and a PPV of 98%. The present study was per-
formed in the same clinic as that of Hartmann et al,15 and 
drew cats from the same clinic population, only at a later 
time point, thus allowing the assumption that the cat 
populations were very similar and enabling the applica-
tion of the PPV calculated in that study. Based on the 
PPV of 98%, serum γ-globulins in the current study had 
a high diagnostic value in about half of the cats in which 
they were performed.
An increase in total protein, which is composed of the 
globulin fractions, as well as albumin, is often consid-
ered the most common laboratory abnormality in cats 
with FIP.16,56 However, while studies exist documenting 
a high prevalence of elevated serum protein levels in cats 
with FIP,4,19,60 other studies have reported hyperpro-
teinaemia in a considerably lower percentage.10,19,20 
Thus, Sparkes et al detected high total protein levels in 
only 39% of cats with FIP.19 Moreover, the current study 
documented hyperproteinaemia in only 17.5% (32/183) 
of cats. Similar to a study by Pedersen,61 an increase in 
total protein was significantly more common in cats 
without than with effusion. The most likely explanation 
for the low percentage of cats with hyperproteinaemia in 
the present study is the high prevalence of hypoalbumi-
naemia, observed in 64.5% of cats. The fact that hypoal-
buminaemia and effusion caused by extravasation of 
protein-rich fluids are common findings in cats with 
FIP,16,47 leading to a decrease in total protein values, sug-
gests that serum total protein is not a reliable diagnostic 
marker for FIP.
A:G ratio, the second serum parameter that takes 
globulins and albumin into account, presents a more 
valuable diagnostic tool than total protein levels.15,62,63 
Serum A:G ratio decreases in cats with FIP because, as 
discussed above, globulin levels usually increase while 
albumin levels tend to decrease.4,15,63 Hypoalbuminaemia 
in cats with FIP is most commonly attributable to 
extravasation secondary to vasculitis in cats with effu-
sion and, especially in cases of only slight decreases in 
albumin levels, to albumin’s role as a negative acute 
phase protein.23,64 Thus, in the current study, 64.5% 
(118/183) of cats with FIP were hypoalbuminaemic, 
and decreased albumin levels were correlated to effu-
sion. A:G ratio, in contrast, was not associated with 
effusion, indicating that globulin concentration is a 
weightier determinant of A:G ratio than the albumin 
level. Similar to Rohrer et  al,4 85% (155/183) of cats 
with FIP had an A:G ratio with an optimal cut-off value 
of <0.8.15,63 In the study by Hartmann et al,15 a cut-off 
value <0.8 was associated with a specificity of 79%, a 
sensitivity of 87% and a PPV of 80%.15 While the selec-
tion of lower cut-off values increases the specificity and 
PPV of A:G ratio, it also decreases sensitivity.15 In the 
current study, 67.8% (124/183) of cats had an A:G ratio 
<0.6, which had a specificity of 85%, a sensitivity of 
67% and a PPV of 83%.15 Comparing the present study 
to that of Hartmann et al,15 the proportion of infected 
cats with a decreased A:G ratio was very similar for 
both cut-off values, which most likely reflects the 
similar study populations.
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Conclusions
As previously established, young age and male sex were 
significantly correlated with FIP, while reproductive sta-
tus of neither sex was associated with disease. Microcytosis 
with and without anaemia was common, suggesting that 
the presence of this laboratory abnormality in a cat with 
other clinical and laboratory parameters consistent with 
FIP can increase suspicion of this disease. Lymphopenia 
and hyperbilirubinaemia, both considered typical labora-
tory abnormalities in cats with FIP, were observed infre-
quently in cats without effusion. Over a third of cats with 
a left shift lacked a mature neutrophilia, a finding more 
expected in sepsis,50,51 which could potentially complicate 
the differentiation of effusive FIP from septic peritonitis, 
especially in cats without toxic change or those pretreated 
with antibiotics. Hyperproteinaemia, commonly consid-
ered a frequent finding in cats with FIP,15,56 was observed 
in only <20% of cats, indicating that serum total 
protein is not a reliable diagnostic parameter for FIP. 
Hyperglobulinaemia was detected in 89.1% of cats with 
FIP, suggesting that this is a fairly sensitive albeit non-
specific diagnostic test in cats with and without effusion. 
While only measured in a relatively small number of cats, 
serum γ-globulins had a high diagnostic value (based on a 
PPV of 98%)15 in approximately half of the 47 cats on 
which it was performed. An A:G ratio <0.8, detected in 
85% of cats with FIP, was also considered to be of diagnos-
tic value based on the specificity and PPV determined by 
Hartmann et al.15
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